'No-Frills Prils': GPs' views on drug costs and therapeutic interchange of angiotensin-converting enzyme inhibitors: a qualitative study
Hok Lim, Lena Sanci, Susan Webster, Alyce N Wilson, Phyllis Lau
AUSTRALIAN JOURNAL OF PRIMARY HEALTH | CSIRO PUBLISHING | Published : 2021
Medications form a significant portion of spending in primary health care. Angiotensin-converting enzyme inhibitors (ACE-Is) are among the most prescribed blood pressure medications in general practice. Medications within this class are considered therapeutically equivalent, but the cost of each ACE-I varies. Our aim was to explore cost and other factors that influence general practitioners (GPs) to prescribe a specific ACE-I and understand their views on therapeutic interchange within this drug class. We conducted a qualitative study of Australian GPs using thematic analysis. We found that GPs were aware of therapeutic equivalency within the ACE-I class, but unaware of the cost differences...View full abstract
We thank the clinicians that were interviewed, Stephen Duckett for his input early into the development of this project and the Pharmaceutical Benefits Scheme for information on drug costs. This study was completed as a part of HL's Academic General Practice Registrar extended skills post and received funding through the Australian General Practice Training program (AGPT). The funder had no role in the development of this project and was independent of the researchers.